Gilead Sciences, Inc.GILDNASDAQ
Loading
R&D Expenses Over TimeStable
Percentile Rank86
3Y CAGR+4.5%
5Y CAGR+2.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.5%/yr
vs +6.2%/yr prior
5Y CAGR
+2.4%/yr
Consistent
Acceleration
-1.6pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.69B | -3.7% |
| 2024 | $5.91B | +3.3% |
| 2023 | $5.72B | +14.9% |
| 2022 | $4.98B | +8.2% |
| 2021 | $4.60B | -8.7% |
| 2020 | $5.04B | +24.3% |
| 2019 | $4.05B | +3.4% |
| 2018 | $3.92B | +5.0% |
| 2017 | $3.73B | -26.8% |
| 2016 | $5.10B | - |